Cole Bunn

Cole Bunn began their work experience in 2014 as an Analyst (Intern) at Fenox Venture Capital. Cole then worked as an Assistant Account Executive at LaVoieHealthScience from December 2014 to September 2015. From September 2015 to July 2016, Cole served as a Research Analyst at Life Science Nation before being promoted to Senior Research Analyst from July 2016 to July 2018. Cole then joined UCSF Innovation Ventures in October 2018 as a Licensing Associate, where they worked until March 2021. Currently, Cole is employed at Claritas Rx as a Business Development Manager.

Cole Bunn pursued their education at the University of Alabama at Birmingham, where they completed their Bachelor of Science (BS) degree in Molecular Biology from 2008 to 2013. Cole furthered their studies at the same university and obtained a Master of Science (MS) degree in Biotechnology from 2013 to 2014. In addition to their academic qualifications, Cole Bunn also holds certifications including the Series 63 and Series 7, issued by the Financial Industry Regulatory Authority (FINRA). However, specific dates of when they obtained these certifications are not provided.